pre-IPO PHARMA

COMPANY OVERVIEW

EIP Pharma, Inc. is a private, Cambridge, MA-based company advancing CNS-focused therapeutics for improved patient benefit.


LOCATION

  • Cambridge, MA, USA

  • THERAPEUTIC AREAS

  • Neurodegenerative Disease

  • WEBSITE

    https://www.eippharma.com


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    adage-capital-management mossrock-capital rock-springs-capital


    PRESS RELEASES


    Aug 16, 2023

    CervoMed Announces Completion of Merger with EIP Pharma


    Aug 14, 2023

    EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies


    Aug 3, 2023

    EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference


    May 11, 2023

    EIP Pharma to Present at JMP Securities Life Sciences Conference


    Apr 3, 2023

    EIP Pharma Announces Presentation of Neuroimaging Data Exhibiting Potential Effects of Neflamapimod on Cholinergic Structure and Function at AD/PD™ 2023


    For More Press Releases


    Google Analytics Alternative